Lorven Biologics

Semaglutide is a cutting-edge GLP-1 receptor agonist developed for the treatment of type 2 diabetes and obesity

  • Manufactured to meet stringent quality control standards
  • Available in bulk quantities to meet global demands
  • Adheres to US FDA, EMA, and WHO-GMP guidelines.

Product application

  • • Used in the formulation of diabetes management medications.
  • • Supports weight loss therapies.
  • • Suitable for pharmaceutical and research applications.
Connect to Explore More

Semaglutide is a cutting-edge GLP-1 receptor agonist developed for the treatment of type 2 diabetes and obesity. It helps regulate blood sugar levels, reduce appetite, and support weight management. Our high-quality Semaglutide supply meets global pharmaceutical standards, ensuring safety, efficacy, and consistency.

Key features & Benefits

  • State-of-the-Art Manufacturing: Advanced biopharmaceutical production facility.
  • Stringent Quality Control: In-depth analysis to ensure product consistency.
  • Reliable Supply Chain: Efficient logistics for seamless global distribution.
  • Expert Support: Technical and regulatory assistance available.

Key features & Benefits

  • Chemical Name: Semaglutide
  • Molecular Formula: C187H291N45O59
  • Molecular Weight: 4113.64 g/mol
  • Appearance: White to off-white powder
  • Storage Conditions: Store at -20°C for long-term stability

Our trusted partners

Empowering discovery through effective partnerships

  • NAARM & a-IDEA
  • KIIT & KIIT-TBI
  • Vignan's
  • BIRAC